Advancing health, together

Our new recombinant Glucose Dehydrogenase enzyme.

We’re excited to introduce a recombinant FAD-dependent Glucose Dehydrogenase (FAD-GDH) designed for use in continuous glucose monitoring devices – supporting more accurate and reliable diabetes management.

BBI offers a next generation FAD-Dependent Glucose Dehydrogenase (FAD-GDH). FAD-GDH with reduced xylose interference is part of our market leading range of enzymes for blood glucose monitoring, it reduces crossreactivity with a range of sugars, provides increased specificity to glucose and improves reactivity and stability.